SARONG-II Trial

About this trial

The study aims to recruit at least 952 participants in Europe over a 32-month period. Patients undergoing surgery for oesophageal or stomach cancer will be invited to participate in the study at around 4 to 8 weeks after their surgery.

(i) The imaging surveillance group will receive a review in clinic or by telephone with a member of the surgical team, and a radiological scan at 6, 12, 18, 24, 30 and 36 months after randomisation. They will also receive endoscopy at 12 months after randomisation (ii) The clinical surveillance group will receive a review in clinic or by telephone at 6, 12, 18, 24, 30 and 36 months. After this they will be either discharged to their local doctor or receive a review in clinic with a member of the surgical team every year according to local practice

Patient Profile

The SARONG-II trial will recruit adults (aged 18 years or over) receiving surgical resection for curatively intended treatment of oesophageal or gastric cancer with or without neoadjuvant/adjuvant chemo(radio)therapy. Patients must be willing and able to give informed consent.

Where’s this trial being run?

St James’s Hospital

Can I join this study / trial?

The first thing you do is to talk to your doctor and/or the cancer trials research team in your hospital. The contact details for the cancer trials research units in Ireland is here.

Why not Print this page and bring it with you. It will help your doctor and research team advise you.

Print this page

For more detailed information

Click Here

Questions?

Here’s a list of questions you may have for your doctor or local cancer research team.

Questions

---

Summary Data

Name:	SARONG-II Trial
Number:	CTRIAL-IE 24-01
Full Title:	Open label international multicentre randomised controlled trial of intensive surveillance vs. standard postoperative follow-up in patients undergoing surgical resection for oesophageal and gastric cancer (Surveillance After Resection of Oesophageal aNd Gastric cancer

Principal Investigator:	Dr Jessie Elliot
Type:	Collaborative
Sponsor:	Trinity St James’s Cancer Institute
Recruitment Started:	Global: May 2024 Ireland: May 2024

Global Recruitment Target:	952
Ireland Recruitment Target:	To be confirmed